Low-drift aqueous liquid formulations for low-volume application, medium-volume application, and high-volume application

Abstract

The present invention is directed to low-drift aqueous liquid formulations for low-volume application, medium-volume application, and high-volume application, which comprise combinations of different drift-reducing agents.

Description

Technical Field

[0001] The present invention is directed to a low-drift aqueous liquid formulation for low-volume application, medium-volume application, and high-volume application, which contains a combination of different drift-reducing agents.

Background Art

[0002] Low-volume and medium-volume spraying applications are becoming increasingly popular because they require less water, a lighter vehicle, and, in some cases, fewer adjuvants introduced into the environment.

[0003] However, currently commercially available formulations can often be used only at high or medium spray volumes, or only at low or medium spray volumes, and do not cover the entire range. Nevertheless, for farmers, it would be desirable and economically feasible if one type of formulation could be used for all types of applications, depending on the application method, requirements, environmental conditions, etc.

[0004] On the other hand, it is economically advantageous for suppliers to offer only one type of formulation for the entire range.

[0005] In the art, it is known that different drift-reducing additives act more effectively at different spray volumes because the concentration in the diluted spray liquid is different.

[0006] Polymeric drift-reducing additives are most effective at high concentrations where their viscosity-increasing effect is strong. However, there is an upper limit to the viscosity of the drift-reducing polymer, which increases the viscosity of the flowable formulation, and beyond which the formulation becomes too thick to be usable. As a result, when the amount of polymer is high, the viscosity of the formulation becomes too high to be usable. Therefore, in a formulation of 1 L / ha, when spraying at a high spray liquid volume, it is difficult to contain enough polymer to reduce drift. However, this is not the case when the spray liquid volume is low, and much less polymer is required in the formulation to provide an effective concentration in the spray liquid. Conversely, a formulation containing enough polymer to reduce drift at a high spray liquid volume becomes impossible to spray at a low spray liquid volume, and at that time, the high polymer concentration stops the atomization process, thereby making the spray liquid impossible to spray.

[0007] Oil-based drift-reducing additives work well over a wide concentration range. However, their effects can be reduced by surfactants required in the formulation as dispersants, wetting agents, spreading agents, or uptake promoters. As a result, oil-based drift-reducing additives can lose their effects at low spray liquid volumes where the concentration of these surfactants in the spray liquid is higher.

[0008] Therefore, there is a need for a drift-reducing additive that can act at both low and high spray liquid volumes without causing high viscosity or other undesirable effects in the formulation. This is achieved by the present invention in which both polymeric drift-reducing additives and oil-based drift-reducing additives are combined at effective levels in the formulation. The present invention is particularly beneficial when the formulation contains surfactant-based spreading additives and uptake-promoting additives, because without the present invention, these formulations have a high risk of drift and off-field losses.

[0009] The combination of hydroxypropylated guar gum or other guar gums and oil in a drift-reducing composition has already been disclosed in US2002 / 108415A1, WO2022 / 023255A1, WO2021 / 127865A1 and US2018 / 184647A1. However, the oil component is always used in extremely large amounts and serves different purposes in addition to drift reduction, for example, as a carrier and uptake promoter.

[0010] In addition to the drift-reducing effect, oil is also commonly used as an uptake promoter, but in this case, the required amount is extremely large, typically 100 - 500 g / ha, thereby leaving little space to incorporate a second polymer drift-reducing agent in the formulation. In this regard, the amount of drift-reducing oil in the formulation according to the present invention is much less than 100 g / ha, thereby making it possible to easily incorporate a second polymer drift-reducing agent in the formulation.

[0011] Furthermore, the concentration of various surfactant-based components in the formulation increases as the spray liquid volume decreases. If the concentration of these surfactants is relatively high at low spray liquid volumes, it can neutralize the drift-reducing effect of the oil. Therefore, a second drift-reducing agent capable of reducing drift even in the presence of a relatively high concentration of surfactants is required. This can be achieved by a drift-reducing polymer. Furthermore, in this regard, it is important to note that each additional adjuvant can not only affect the efficacy and handling of the formulation, but also physically and chemically interact with other adjuvants and active ingredients, thereby resulting in an unstable or less effective formulation.

Prior Art Documents

Patent Documents

[0012]

Patent Document 1

Patent Document 2

[0013] Surprisingly, it has been found that pesticide formulations containing a combination of a particular polymer and oil at quite low concentrations reduce the drift of the formulation over a wide range of spray volumes. [Brief Description of the Drawings]

[0014]

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

Figure 11

Figure 12

Figure 13

Figure 14

Mode for Carrying Out the Invention

[0015] Each formulation is described below.

[0016] In one aspect, the present invention relates to an agrochemical formulation comprising the following: (a) One or more active ingredients; (b) One or more polymer-based drift-reducing additives selected from the group consisting of poly(ethylene oxide) (hereinafter, PEO) and hydroxypropylated guar (hereinafter, HP guar); (c) One or more oily drift-reducing additives; (d) One or more spreading agents and / or uptake-promoting additives; (e) Other formulation aids; (f) At least one type of carrier is water, one or more carriers up to a predetermined volume; Here, (a) is present at 10 - 550 g / L, preferably at 15 - 300 g / L, more preferably at 20 - 200 g / L; Here, (b) is present at 0.2 - 50 g / L, preferably at 0.5 - 40 g / L, more preferably at 1 - 15 g / L; Here, (c) is present at 0.5 - 45 g / L, preferably at 1 - 30 g / L, more preferably at 5 - 25 g / L; Here, (d) is present at 10 - 200 g / L, preferably at 20 - 160 g / L, more preferably at 25 - 140 g / L; and, Here, (e) is present at 20 - 300 g / L, preferably at 30 - 180 g / L, more preferably at 30 - 135 g / L.

[0017] In a preferred embodiment, (a) is present at 10 - 550 g / L; (b) is present at 0.2 - 50 g / L; (c) is present at 0.5 - 45 g / L; (d) is present at 10 - 200 g / L; (e) is present at 20 - 300 g / L; (f) carriers up to a predetermined volume.

[0018] In a more preferred embodiment, (a) is present at 15 - 300 g / L; (b) is present at 0.5 - 40 g / L; (c) is present at 1 - 30 g / L; (d) is present at 20 - 160 g / L; (e) is present at 30 - 180 g / L; (f) carriers up to a predetermined volume.

[0019] In an even more preferred embodiment, (a) is present at 20 - 200 g / L; (b) is present at 1 - 15 g / L; (c) is present at 5 - 25 g / L; (d) is present at 25 - 140 g / L; (e) is present at 30 - 135 g / L; (f) Carrier up to a predetermined volume.

[0020] When combining various components, it is understood that the percentages of all components of the formulation always total 100.

[0021] Unless otherwise indicated, “%” in this application means weight percent (% w / w).

[0022] Furthermore, unless otherwise indicated, the reference to “to volume” with respect to the carrier indicates that the carrier (in particular, water) is added until it reaches 1000 mL (1 L), which is the total volume of the formulation. For clarity, when it is unclear, the density of the formulation is understood to be 1 g / cm 3 It is understood that it is so.

[0023] Unless otherwise defined in this application, the molecular weight refers to the weight - average molecular weight Mw measured by GPC at 25 °C in methylene chloride using polystyrene as the standard.

[0024] In connection with the present invention, the formulation can be applied using a wide range of spraying liquid volumes from 1 L / ha to 2000 L / ha, preferably from 5 L / ha to 1500 L / ha, more preferably from 8 L / ha to 1200 L / ha.

[0025] Accordingly, a further aspect of the present invention is a method of applying a formulation according to the present invention to a crop, wherein the formulation is applied at a spraying liquid volume of 1 L / ha to 2000 L / ha, preferably 5 L / ha to 1500 L / ha, more preferably 8 L / ha to 1200 L / ha.

[0026] Accordingly, another aspect of the present invention is the use of the formulation according to the present invention for application to crops, wherein the formulation is applied at a spray liquid volume of 1 L / ha to 2000 L / ha, preferably 5 L / ha to 1500 L / ha, more preferably 8 L / ha to 1200 L / ha.

[0027] Furthermore, in the case of a low spray liquid volume, the formulation according to the present invention is applied at a spray liquid volume of 1 to 25 L / ha, preferably 2 to 20 L / ha, more preferably 5 to 15 L / ha.

[0028] Accordingly, a further aspect of the present invention is a method for applying the formulation according to the present invention to crops, wherein the formulation is applied at a spray liquid volume of 1 to 25 L / ha, preferably 2 to 20 L / ha, more preferably 5 to 15 L / ha.

[0029] Accordingly, another aspect of the present invention is the use of the formulation according to the present invention for application to crops, wherein the formulation is applied at a spray liquid volume of 1 to 25 L / ha, preferably 2 to 20 L / ha, more preferably 5 to 15 L / ha.

[0030] Preferably, the formulation is applied at the above spray liquid volume as a spray liquid containing the formulation.

[0031] The ratio of (b) to (c) in the formulation according to the present invention is 1:40 to 10:1, more preferably 1:10 to 5:1, and most preferably 1:6 to 2:1.

[0032] The ratio of (b) to (c) to (d) in the formulation according to the present invention is 1:40:150 to 10:1:10, more preferably 1:12:120 to 2:1:5, and most preferably 1:8:50 to 1:2:5.

[0033] Preferably, the above ratio is the same for the spray liquid containing the formulation.

[0034] A further aspect of the present invention is the use of the formulation according to the present invention for delivery to an agricultural target area.

[0035] (b) The amount is 0.5 to 15 g / ha, more preferably 1 to 12 g / ha, and most preferably 1 to 10 g / ha.

[0036] (c) The amount is 0.5 to 40 g / ha, more preferably 1 to 20 g / ha, and most preferably 2 to 10 g / ha.

[0037] (d) The amount is 10 to 200 g / ha, more preferably 15 to 160 g / ha, and most preferably 20 to 100 g / ha.

[0038] In a more preferred embodiment of the present invention, the formulation consists only of the components (a) to (f) described above in the specified amounts and ranges.

[0039] Furthermore, it is understood that the preferred given ranges of the application volume or application rate, and the preferred given ranges of each component described in the present application can be freely combined, and all combinations are disclosed in this specification. In a more preferred embodiment, the components are preferably present within the same degree of preferred range, and even more preferably, it is understood that the components are present within the most preferred range.

[0040] In relation to the present invention, the appropriate types of formulations are, by definition, suspension concentrate, aqueous suspension, suspo-emulsion, capsule suspension, aqueous dispersion concentrate, soluble liquid, aqueous emulsion or aqueous emulsion concentrate, and preferably suspension concentrate, aqueous suspension and suspo-emulsion.

[0041] Active ingredient (a): In the present specification, the active compounds identified by their common names are known and are described, for example, in the Pesticide Manual ("The Pesticide Manual" 16th Ed., British Crop Protection Council 2012) or can be found on the Internet (e.g., http: / / www.alanwood.net / pesticides). The classification is based on the current "IRAC Mode of Action Classification Scheme" at the time of filing of this patent application.

[0042] The active ingredient (a) is preferably a pesticidal active compound selected from fungicides, herbicides or insecticides.

[0043] Examples of the fungicide (a) according to the present invention are as follows.

[0044] (1) Inhibitors of ergosterol biosynthesis, for example, (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenhexamid, (1.005) fenpropizine, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole, (1.009) flutriafol, (1.010) imazalil, (1.011) imazalil sulfate, (1.012) ipconazole, (1.013) metconazole, (1.014) myclobutanil, (1.015) paclobutrazol, (1.016) procraz, (1.017) propiconazole, (1.018) prothioconazole, (1.019) pyrisoxazole, (1.020) spiroxamine, (1.021) tebuconazole, (1.022) tetraconazole, (1.023) triadimenol, (1.024) tridemorph, (1.025) triticonazole, (1.026) (1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.027) (1S,2R,5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.028) (2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1.029) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.030) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.031) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.(2S)-2-(1-Chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.033)(2S)-2-[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.034)(R)-[3-(4-Chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.035)(S)-[3-(4-Chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.036)[3-(4-Chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.037)1-({(2R,4S)-2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.038)1-({(2S,4S)-2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.039)1-{[3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxolan-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.040)1-{[rel(2R,3R)-3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxolan-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.041)1-{[rel(2R,3S)-3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxolan-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.042)2-[(2R,4R,5R)-1-(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.043) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.044) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.046) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.048) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.049) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.050) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.051) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.052) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.053) 2-[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.054) 2-[4-(4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol, (1.055) Mepentrifluconazole, (1.056) 2-{[3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.057) 2-{[rel(2R,3R)-3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.058) 2-{[rel(2R,3S)-3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.059) 5-(4-Chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.060) 5-(Allylsulfanyl)-1-{[3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.061) 5-(Allylsulfanyl)-1-{[rel(2R,3R)-3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.062) 5-(Allylsulfanyl)-1-{[rel(2R,3S)-3-(2-Chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazole, (1.063) N'-(2,5-Dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidformamide, (1.064) N'-(2,5-Dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidformamide, (1.065) N'-(2,5-Dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.066) N'-(2,5-Dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.067) N'-(2,5-Dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.068) N'-(2,5-Dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.069) N'-(2,5-Dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.070) N'-(2,5-Dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.071) N'-(2,5-Dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.072) N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.073) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidohydroxamic acid amide, (1.074) N'-[5-Bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylimidohydroxamic acid amide, (1.075) N'-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidohydroxamic acid amide, (1.076) N'-{5-Bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidohydroxamic acid amide, (1.077) N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidohydroxamic acid amide, (1.078) N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidohydroxamic acid amide, (1.079) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidohydroxamic acid amide, (1.080) N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidohydroxamic acid amide. D, (1.081) ipfentrifluconazole, (1.082) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.083) 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.084) 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.085) 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, (1.086) 4-[[6-[rac-(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile, (1.087) N-isopropyl-N’-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenylethyl)phenyl]-N-methylformamide, (1.088) N’-{5-bromo-2-methyl-6-[(1-propoxypropan-2-yl)oxy]pyridin-3-yl}-N-ethyl-N-methylformamide, (1.089) hexaconazole, (1.090) penconazole, (1.091) fenbuconazole.

[0045] (2) Inhibitors of the respiratory chain in Complex I or Complex II, for example, (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) flutriafol, (2.009) isofetamid, (2.010) isopyrazam (anti-epimeric enantiomer 1R,4S,9S), (2.011) isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (2.012) isopyrazam (anti-epimeric racemic compound 1RS,4SR,9SR), (2.013) isopyrazam (syn-epimeric racemic compound (1RS,4SR,9RS) and anti-epimeric racemic compound (1RS,4SR,9SR) mixture), (2.014) isopyrazam (syn-epimeric enantiomer 1R,4S,9R), (2.015) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (2.016) isopyrazam (syn-epimeric racemic compound 1RS,4SR,9RS), (2.017) penthiopyrad, (2.018) penthiopyrad, (2.019) pidiflumetofen, (2.020) pyraziflumid, (2.021) sedaxane, (2.022) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.023) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.024) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.025) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.027) 3-(Difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.028) Imidacloprid, (2.029) 3-(Difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) Fluindapyr, (2.031) 3-(Difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) 3-(Difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.033) 5,8-Difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine, (2.034) N-(2-Cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-Butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-(2-tert-Butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.037) N-(5-Chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.038) Isoflucypram, (2.039) N-[(1R,4S)-9-(Dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.040) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.041) N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.048) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carbothioamide, (2.049) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.051) N-Cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.052) N-Cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.053) N-Cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.054) N-Cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055) N-Cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.056) N-Cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.057) Pyrapropion, (2.058) N-[rac-(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)-nicotinamide, (2.059) N-[(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)nicotinamide.

[0046] (3) Inhibitors of the respiratory chain in complex III, for example, (3.001) ametoctradin, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) cumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadone, (3.010) fenamidone, (3.011) flufenoxystrobin, (3.012) fluoxastrobin, (3.013) kresoxim-methyl, (3.014) metominostrobin, (3.015) orysastrobin, (3.016) picoxystrobin, (3.017) pyraclostrobin, (3.018) pyra-metostrobin, (3.019) pyraoxystrobin, (3.020) trifloxystrobin, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) fenpicoxamid, (3.026) mandestrobin, (3.027) N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029) {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}methylcarbamate, (3.030) methyltetraprole, (3.031) Florilpicoxamide.

[0047] (4) Inhibitors of mitosis and cell division, for example, (4.001) carbendazim, (4.002) diethofencarb, (4.003) etaboxam, (4.004) fluopicolide, (4.005) penthiocarb, (4.006) thiabendazole, (4.007) thiophanate-methyl, (4.008) zoxamide, (4.009) pyridachlometyl, (4.010) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (4.011) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (4.012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.014) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.015) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.016) 4-(2-bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.017) 4-(2-bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.020) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.021) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (4.022) 4-(4-Chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (4.023) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.024) N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.026) Fluopyram.

[0048] (5) Compounds that can exhibit activity at multiple sites, for example, (5.001) Bordeaux mixture, (5.002) Captan, (5.003) Captan, (5.004) Chlorothalonil, (5.005) Copper hydroxide, (5.006) Copper naphthenate, (5.007) Copper oxide, (5.008) Basic copper chloride, (5.009) Copper(II) sulfate, (5.010) Dithianon, (5.011) Dodine, (5.012) Folpet, (5.013) Maneb, (5.014) Mancozeb, (5.015) Metiram, (5.016) Metiram zinc, (5.017) Copper oxine, (5.018) Propineb, (5.019) Sulfur and sulfur agents, for example, calcium polysulfide, (5.020) Thiram, (5.021) Dinneb, (5.022) Ziram, (5.023) 6-Ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3’,4’:5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile.

[0049] (6) Compounds that can induce the host's defense, for example, (6.001) Acibenzolar-S-methyl, (6.002) Isothianyl, (6.003) Probenazole, (6.004) Thiadinyl.

[0050] (7) Inhibitors of the biosynthesis of amino acids and / or proteins, for example, (7.001) Cyprodinil, (7.002) Kasugamycin, (7.003) Kasugamycin hydrochloride hydrate, (7.004) Oxytetracycline, (7.005) Pyrimethanil, (7.006) 3-(5-Fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline.

[0051] (8) Inhibitors of ATP production, for example, (8.001) Silthiopham.

[0052] (9) Inhibitors of cell wall synthesis, for example, (9.001) Benalaxyl-M, (9.002) Dimethomorph, (9.003) Flumorph, (9.004) Iprovalicarb, (9.005) Mandipropamid, (9.006) Pyrimorph, (9.007) Valifenalate, (9.008) (2E)-3-(4-tert-Butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-Butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.

[0053] (10) Inhibitors of lipid and membrane synthesis, for example, (10.001) Propamocarb, (10.002) Propamocarb hydrochloride, (10.003) Tolclofos-methyl.

[0054] (11) Inhibitors of melanin biosynthesis, for example, (11.001) Tricyclazole, (11.002) Tolprocarb.

[0055] (12) Inhibitors of nucleic acid synthesis, for example, (12.001) Benalaxyl, (12.002) Benalaxyl-M (Kiralaxyl), (12.003) Metalaxyl, (12.004) Metalaxyl-M (Mefenoxam).

[0056] (13) Inhibitors of signal transduction, for example, (13.001) fluazinam, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin.

[0057] (14) Compounds that can act as uncoupling agents, for example, (14.001) fluazinam, (14.002) meptyldinocap.

[0058] (15) A further fungicide selected from the group consisting of the following: (15.001) abscisic acid, (15.002) benzothiazole, (15.003) benthiavalicarb, (15.004) capsimycin, (15.005) carvone, (15.006) quinomethionate, (15.007) kresoxim-methyl, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) flutianil, (15.012) fosetyl-aluminum, (15.013) fosetyl-calcium, (15.014) fosetyl-sodium, (15.015) methyl isothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) nickel dimethyldithiocarbamate, (15.020) nitrothal-isopropyl, (15.021) oxamocarb, (15.022) oxathiapiprolin, (15.023) oxyfenthiin, (15.024) pentachlorophenol and salts thereof, (15.025) phosphonic acid and salts thereof, (15.026) propamocarb-fosetylate, (15.027) pyriofenone (chlazafenone), (15.028) tebufloquin, (15.029) tecnazene, (15.030) tolfenpyrad, (15.031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.032) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.033) 2-(6-benzylpyridin-2-yl)quinazoline, (15.034) diphenamidone, (15.(15.035) 2-[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.036) 2-[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.037) 2-[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.038) 2-[6-(3-Fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline, (15.039) 2-{ (5R)-3-[2-(1-{[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.040) 2-{ (5S)-3-[2-(1-{[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.041) Ipfuphenoxine, (15.042) 2-{2-Fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (15.043) Fluoxapiprolin, (15.044) 2-{3-[2-(1-{[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, (15.045) 2-Phenylphenol and salts, (15.046) 3-(4,4,5-Trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.047) Quinofumelin, (15.048) 4-Amino-5-fluoropyrimidin-2-ol (tautomeric form: 4-Amino-5-fluoropyrimidin-2(1H)-one), (15.049) 4-Oxo-4-[(2-phenylethyl)amino]butanoic acid, (15.050) 5-Amino-1,3,4-thiadiazole-2-thiol, (15.051) 5-Chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide, (15.052) 5-Fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.053) 5-Fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine, (15.054) 9-Fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepine, (15.055) But-3-yn-1-yl {6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.056) (2Z)-3-Amino-2-cyano-3-phenylacrylic acid ethyl ester, (15.057) Phenazine-1-carboxylic acid, (15.058) Propyl 3,4,5-trihydroxybenzoate, (15.059) Quinolin-8-ol, (15.060) Quinolin-8-ol sulfate (2:1), (15.061) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamic acid tert-butyl, (15.062) 5-Fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one, (15.063) Aminopyrifen, (15.064) (N'-[2-Chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylimid-formamide), (15.065) (N'-(2-Chloro-5-methyl-4-phenoxyphenyl)-N-ethyl-N-methylimidformamide), (15.(066)(2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol), (15.067)(5-bromo-1-(5,6-dimethylpyridin-3-yl)-3,3-dimethyl-3,4-dihydroisoquinoline), (15.068)(3-(4,4-difluoro-5,5-dimethyl-4,5-dihydrothieno[2,3-c]pyridin-7-yl)quinoline), (15.069)(1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline), (15.070)8-fluoro-3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinolone, (15.071)8-fluoro-3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinolone, (15.072)3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-8-fluoroquinoline, (15.073)(N-methyl-N-phenyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (15.074)methyl {4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}carbamate, (15.075)(N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}cyclopropanecarboxamide), (15.076)N-methyl-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.077)N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.078)N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.079)N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide, (15.080)N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.081) 2,2-Difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide, (15.082) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl]methyl]acetamide, (15.083) N-[(E)-N-methoxy-C-methyl-carboximidoyl]-4-(5-(trifluoro-methyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.084) N-[(Z)-N-methoxy-C-methyl-carboximidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.085) N-allyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.086) 4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.087) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzenecarbothioamide, (15.088) 5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.089) N-((2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoro-propanamide, (15.090) 1-methoxy-1-methyl-3-[[4-[5-(trifluoro-methyl}-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.091) 1,1-diethyl-3-[[4-[5-(trifluoromethyl}-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.092) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.093) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]-methyl]cyclopropanecarboxamide, (15.094) 1-Methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.095) N-Methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl)cyclopropanecarboxamide, (15.096) N,2-Dimethoxy-N-[[4-[5-(trifluoromethyl}-1,2,4-oxadiazol-3-yl. phenyl]methyl]propanamide, (15.097) N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl]methyl]propanamide, (15.098) 1-methoxy-3-methyl-1-[[4-[5-(trifluoro-methyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.099) 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.100) 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.101) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]-methyl]piperidin-2-one, (15.102) 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]-methyl]isoxazolidin-3-one, (15.103) 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.104) 3,3-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one, (15.105) 1-[[3-fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-phenyl]methyl]azepan-2-one, (15.106) 4,4-dimethyl-2-[[4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-phenyl]methyl]isoxazolidin-3-one, (15.107) 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.108) ethyl 1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}-1H-pyrazole-4-carboxylate, (15.109) N,N-dimethyl-1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}-1H-1,2,4-triazol-3-amine, (15.110) N-{2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}butanamide, (15.111) N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.112) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.113) 1-(5,6-dimethylpyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.114) 1-(6-(difluoromethyl)-5-methyl-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydro-isoquinoline, (15.115) 1-(5-(fluoromethyl)-6-methyl-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.116) 1-(6-(difluoromethyl)-5-methoxy-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.117) 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl dimethyl-carbamate, (15.118) N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}propanamide, (15.119) 3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.120) 9-fluoro-3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.121) 3-[2-(1-{[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.122) 3-[2-(1-{[3,5-Bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-9-fluoro-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.123) 1-(6,7-Dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.124) 8-Fluoro-N-(4,4,4-trifluoro-2-methyl-1-phenylbutan-2-yl)quinoline-3-carboxamide, (15.125) 8-Fluoro-N-[(2S)-4,4,4-trifluoro-2-methyl-1-phenylbutan-2-yl]quinoline-3-carboxamide, (15.126) N-(2,4-Dimethyl-1-phenylpentan-2-yl)-8-fluoroquinoline-3-carboxamide, and, (15.127) N-[(2S)-2,4-Dimethyl-1-phenylpentan-2-yl]-8-fluoroquinoline-3-carboxamide.

[0059] Examples of the insecticide (a) according to the present invention are as follows.

[0060] (1) Acetylcholinesterase (AChE) inhibitors, for example, carbamates, alanycarb, aldicarb, benfuracarb, benoxacarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC and xylylcarb; or, Organophosphates, such as acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, kasugamycin, chlorethoxyfos, chlorfenvinphos, chloromephos, chlorpyrifos-methyl, coumaphos, cyanophos, dimethoate-S-methyl, diazinon, dichlorvos / DDVP, dichlorvos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fostiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl) salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiamethoxam, triazophos, trichlorfon, and bamidothion.

[0061] (2) GABA-regulated chloride channel antagonists, preferably, Cyclodiene-organochlorines, which are selected from the group consisting of chlordane and endosulfan; or, Phenylpyrazoles (fiproles), which are selected from the group consisting of ethiprole and fipronil.

[0062] (3) Sodium channel modulators / voltage-dependent sodium channel blockers, such as, Pyrethroids, for example, acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans-isomer], deltamethrin, empenthrin [(EZ)-(1R)-isomer], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucitrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, monofluoroethrin, permethrin, phenothrin [(1R)-trans-isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R)-isomer], tralomethrin and transfluthrin; or, DDT; or, methoxychlor.

[0063] (4) Nicotinic acetylcholine receptor (nAChR) competitive activators, preferably, Neonicotinoids, which are selected from acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or, Nicotine; or, Sulfoximines, which are selected from sulfoxaflor; or, Butenolides, which are selected from flupyradifurone; or, Mesions, which are selected from triflumizopyrim.

[0064] (5) Nicotinic acetylcholine receptor (nAChR) allosteric activators, preferably, Spinosyns, which are selected from spinetoram and spinosad.

[0065] (6) Allosteric modulators of the glutamate-dependent chloride channel (GluCl), preferably, Avermectin / milbemycin series, which is selected from abamectin, emamectin benzoate, lepimectin and milbemycin.

[0066] (7) Juvenile hormone mimics, preferably, Juvenile hormone analogs, which are selected from hydroprene, kinoprene and methoprene; or, Phenoxycarb; or pyriproxyfen.

[0067] (8) Various unspecified (multi-site) inhibitors, preferably, Halogenated alkyl series, which is selected from methyl bromide and another halogenated alkyl; or, Chloropicrin; or sulfuryl fluoride; or borax; or tartar emetic; or, Methyl isocyanate products, which are selected from diazomet and metam.

[0068] (9) TRPV channel modulators of the chordotonal organ, which are selected from pimetrozine and pyrifluquinazone.

[0069] (10) Mite growth inhibitors, which are selected from clofentezine, hexythiazox, diflovidazin and etoxazole.

[0070] (11) A microbial disruptor of the insect midgut, which is selected from Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis, and Bt plant proteins (which are selected from Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, and Cry34Ab1 / 35Ab1).

[0071] (12) An inhibitor of mitochondrial ATP synthase, preferably, an ATP disruptor, which is selected from diafenthiuron; or, an organotin compound, which is selected from azocyclotin, cyhexatin, and fenbutatin oxide; or, propargite; or tetradifon.

[0072] (13) An uncoupler of oxidative phosphorylation by disrupting the proton gradient, which is selected from chlorfenapyr, DNOC, and sulfiram.

[0073] (14) A nicotinic acetylcholine receptor channel blocker, which is selected from bensultap, cartap hydrochloride, thiocyclam, and thiosultap-sodium.

[0074] (15) Inhibitors of chitin biosynthesis (Type 0), which are selected from bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.

[0075] (16) Inhibitors of chitin biosynthesis (Type 1), which are selected from buprofezin.

[0076] (17) Molting disruptors (especially Diptera, i.e., two-winged insects), which are selected from cyromazine.

[0077] (18) Ecdysone receptor agonists, which are selected from chromafenozide, halofenozide, methoxyfenozide and tebufenozide.

[0078] (19) Octopamine receptor agonists, which are selected from amitraz.

[0079] (20) Inhibitors of mitochondrial complex III electron transport, which are selected from hydramethylnon, acequinocyl and fluacrypyrim.

[0080] (21) Inhibitors of mitochondrial complex I electron transport, preferably So-called METI acaricides, which are selected from phenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad; or, Rotenone (Derris).

[0081] (22) Blockers of voltage-dependent sodium channels, which are selected from indoxacarb and metaflumizone.

[0082] (23) Inhibitors of acetyl-CoA carboxylase, preferably Tetronic acid derivatives and tetramic acid derivatives, which are selected from spirodiclofen, spirodiclofen, spirotetramat and spidoxamate (IUPAC name: 11-(4-chloro-2,6-xylyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one).

[0083] (24) Mitochondrial complex IV electron transport inhibitors, preferably Phosphine-based, which is selected from aluminum phosphide, calcium phosphide, phosphine and zinc phosphide; or, Cyanides, which are selected from calcium cyanide, potassium cyanide and sodium cyanide.

[0084] (25) Mitochondrial complex II electron transport inhibitors, preferably β-ketonitrile derivatives, which are selected from cyenopyrafen and cifulmetofen; or, Carboxyanilide-based, which is selected from piflubumide.

[0085] (28) Ryanodine receptor modulators, preferably Diamide-based, which is selected from chlorantraniliprole, cyantraniliprole and flubendiamide.

[0086] (29) Modulators of the chordotonal organ (target structure not defined), which is selected from flonicamid.

[0087] (30) Another active ingredient selected from the following: acinonapyr, afidopyropen, afoxolenaer, azadirachtin, benclothiaz, benzoximate, benzpyramoxan, bifenazate, broflanilide, bromopropylate, chinomethionat, chloroprallethrin, cryolite, cyclaniliprole, cycloxaprid, cyhalodiamide, dichloromezothiaz, dicofol, dimpropyridaz, ε-methofluthrin, ε-momfluthrin, flometokine, fluazaindoline, fluensulfone, flufenoxuron, fluopicoxystrobin, flupyradifurone, flufexaflone, fluopyram, flupyrimin, fluralaner, flucetoxamid, fufenozide, guazatine, heptafluthrin, imidaclothiz, iprodione, isocycloseram, κ-bifenthrin, κ-tefluthrin, lotilaner, meperfluthrin, oxathiazin-sulfur, paichongding, pyridalyl, pyrifluxadine, pyriminostrobin, spirobudiclofen, spirodiclofen, tetramethrin, tetraniliprole, tetrachlorantraniliprole, tigolaner, thioxazafen, thiofluoximate, and iodomethane; products derived from Bacillus firmus (I-1582, BioNeem, Votivo), and the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO2006 / 043635) (CAS 885026-50-6), {1’-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4'-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO2003 / 106457) (CAS 637360-23-7), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006 / 003494) (CAS 872999-66-1), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]deca-3-en-2-one (known from WO2010052161) (CAS 1225292-17-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]deca-3-en-4-yl ethyl carbonate (known from EP2647626) (CAS 1440516-42-6), 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO2004 / 099160) (CAS 792914-58-0), PF1364 (known from JP2010 / 018586) (CAS-Reg.No.1204776-60-2), (3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoro-propan-2-one (known from WO2013 / 144213) (CAS 1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO2010 / 051926) (CAS 1226889-14-0), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from CN103232431) (CAS 1449220-44-3), 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxide-3-thietanyl)benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-Dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxide-3-thietanyl)benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxide-3-thietanyl)benzamide (known from WO2013 / 050317A1) (CAS 1332628-83-7), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propanamide, (+)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propanamide and (-)-N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]propanamide (known from WO2013 / 162715A2, WO2013 / 162716A2, US2014 / 0213448A1) (CAS 1477923-37-7), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from CN101337937A) (CAS 1105672-77-2), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thiomethyl]phenyl]-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, known from CN103109816A) (CAS 1232543-85-9); N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO2012 / 034403A1) (CAS 1268277-22-0), N-[2-(5-amino-1,3,4-(Thiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from WO2011 / 085575A1) (CAS 1233882-22-8), 4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)pyrimidine (known from CN101337940A) (CAS 1108184-52-6); (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]hydrazinecarboxamide (known from CN101715774A) (CAS 1232543-85-9); cyclopropanecarboxylic acid 3-(2,2-dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl ester (known from CN103524422A) (CAS 1542271-46-4); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from CN102391261A) (CAS 1370358-69-2); 6-deoxy-3-O-ethyl-2,4-di-O-methyl-,1-[N-[4-[1-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]-1H-1,2,[[4-Triazol-3-yl]phenyl]carbamate]-α-L-mannopyranose (known from US2014 / 0275503A1) (CAS 1181213-14-8); 8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (CAS 1253850-56-4), (8-anti)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (CAS 933798-27-7), (8-syn)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-aza-bicyclo[3.2.1]octane (known from WO2007040280A1, WO2007040282A1) (CAS 934001-66-8), N-[3-chloro-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)thio]-propanamide (known from WO2015 / 058021A1, WO2015 / 058028A1) (CAS 1477919-27-9), and N-[4-(aminothioxomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from CN103265527A) (CAS 1452877-50-7), 5-(1,3-dioxan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]-pyrimidine (known from WO2013 / 115391A1) (CAS 1449021-97-9), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (known from WO2014 / 187846A1) (CAS 1638765-58-8), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-2-oxo-1,Ethyl 8-azaspiro[4.5]deca-3-en-4-yl-carboxylate (known from WO2010 / 066780A1, WO2011151146A1) (CAS 1229023-00-0), 4-[(5S)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[(4R)-2-ethyl-3-oxo-4-isoxazolidinyl]-2-methyl-benzamide (known from WO2011 / 067272, WO2013 / 050302) (CAS 1309959-62-3).

[0088] Examples of herbicide (a) according to the present invention are as follows: Acetochlor, asifluorfen, asifluorfen-sodium, acifluorfen, acrolein, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor-potassium, aminocyclopyrachlor-methyl, aminopyralid, amitrole, ammonium sulfamate, anilophos, asulam, atrazine, azafenidin, azimsulfuron, beflubutamid, benazolin, benazolin-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, benzobicyclon, benzofenap, bicyclopyrone, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, bixlozone, bromacil, bromobutide, bromophenoxim, bromoxynil, bromoxynil-butyrate, -potassium, -heptanoate and -octanoate, busoxinone, butachlor, butaphenacyl, butamiphos, butenachlor, butralin, butroxydim, butyrate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, 1-{2-chloro-3-[(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]-6-(trifluoromethyl)phenyl}piperidin-2-one, 4-{2-chloro-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1,3-dimethyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazole-4-carboxylate, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorfluorenol, chlorfluorenol-methyl, chloridazon, chlormuron, chlormuron-ethyl, 2-[2-chloro-4-(methylsulfonyl)-3-(morpholin-4-ylmethyl)benzoyl]-3-hydroxycyclohexa-2-en-1-one, 4-{2-chloro-4-(methylsulfonyl)-3-[(2,2,(2-Trifluoroethoxy)methyl]benzoyl}-1-ethyl-1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazole-4-carboxylate, chlorophthalim, chlorotoluron, chlorothalonil-dimethyl, 3-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-4-hydroxy-1-methylimidazolidin-2-one, chlorosulfuron, cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clathrins, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, chloransulam, chloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyranil, cyclopyrimorate, cycloxydim, cyhalofop, cyhalofop-butyl, cyprodinil, 2,4-D, 2,4-D-butyl, -butyl, -dimethylammonium, -diolamine, -ethyl, 2-ethylhexyl, -isobutyl, -isooctyl, -isopropylammonium, -potassium, -triisopropanolammonium and -trolamine, 2,4-DB, 2,4-DB-butyl, -dimethylammonium, isooctyl, -potassium and -sodium, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosyl-pyrazolate (DTP), dicamba, diclobenil, dichlorprop, dichlorprop-P, dichlofop, dichlofop-methyl, dichlofop-P-methyl, dichlorsulam, difenzoquat, diflufenican, diflufenzoate, diflufenzoate-sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, 3-(2,6-dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1-methylquinazoline-2,4(1H,3H)-dione, 1,3-dimethyl-4-[2-(methylsulfonyl)-4-(trifluoromethyl)benzoyl]-1H-pyrazol-5-yl-1,3-Dimethyl-1H-pyrazole-4-carboxylate, dimetrasulfuron, dinotefuran, dinoterb, diphenamid, diquat, diquat-dibromide, dithiopyr, diuron, DMPA, DNOC, endothal, EPTC, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, ethiozin, ethofumesate, ethoxyphene, ethoxyphene-ethyl, ethoxysulfuron, etobenzanid, ethyl-[(3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetate, F-9600, F-5231, namely, N-{2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxo-4,5-dihydro-1H-tetrazol-1-yl]-phenyl}ethanesulfonamide, F-7967, namely, 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidin-2,4(1H,3H)-dione, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, flumetsuron, flurenol, flurenol-butyl, -dimethylammonium and -methyl, fluoroglycofen, fluoroglycofen-ethyl, fluopropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamon, fluthiacet, fluthiacet-methyl, homomesafen, homomesafen-sodium, halosulfuron, hosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosate-ammonium, -isopropylammonium, -diammonium, -dimethylammonium, -potassium, -sodium and -trimesium, H-9201, namely, O-(2,4-dimethyl-6-nitrophenyl) O-ethyl isopropylphosphoramidothioate, halauxifen, halauxifen-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, namely, 1-(dimethoxyphosphoryl)ethyl-(2,4-(Dichlorophenoxy)acetate, 4-Hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 4-Hydroxy-1-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, (5-Hydroxy-1-methyl-1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxide-2,3-dihydro-1-benzothiophen-5-yl)methanone, 6-[(2-Hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2-methylphenyl)quinazoline-2,4(1H,3H)-dione, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyr-imonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxtynil, ioxtynil-octanoate, -potassium and -sodium, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole, carbutilate, KUH-043, namely, 3-({[5-(Difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole, keto-spiradox, lactofen, lenacil, linuron, MCPA, MCPA-butyl, -dimethylammonium, -2-ethylhexyl, -isopropylammonium, -potassium and -sodium, MCPB, MCPB-methyl, -ethyl and -sodium, mecoprop, mecoprop-sodium and -butyl, mecoprop-P, mecoprop-P-butyl, -dimethylammonium, -2-ethylhexyl and -potassium, mefenacet, mefluizide, mesosulfuron, mesosulfuron-methyl, mesotrione, metobenzthiazuron, metam, metamifop, metazoxolon, metazosulfuron, metobenzthiazuron, methiopyrsulfuron, methiozolin, 2-({2-[(2-methoxyethoxy)methyl]-6-(trifluoromethyl)pyridin-3-yl}carbonyl)cyclohexane-1,3-dione, methyl isothiocyanate, 1-methyl-4-[(3,3,4-trimethyl-1,1-dioxide-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-ylpropane-1-sulfonate, metobromuron, metachlor, S-metachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monolinuron, monosulfuron, monosulfuron-ester, MT-5950, i.e., N-[3-chloro-4-isopropylphenyl]-2-methylpentanamide, NGGC-011, napropamide, NC-310, i.e., [5-(benzyloxy)-1-methyl-1H-pyrazol-4-yl](2,4-dichlorophenyl)methanone, neburon, nicosulfuron, nonanoic acid (pelargonic acid), norflurazon, oleic acid (fatty acid), orben carb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazone, oxasulfuron, oxadi clomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorophenol, pentoxazone, petoxamide, petroleum, fenmedifam, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, profam, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, Fen, pyraflufen-ethyl, pyrazosulfuron, pyrazolate, pyrazosulfuron, pyrazosulfuron-ethyl, pyraclostrobin, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxasulam, cinchlorac, cinmethylin, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, QYM-201, QYR-301, rimsulfuron, flufenoxuron, cyoxydim, siduron, simazine, simetryn, SL-261, sulcotrione, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, SYN-523, SYP-249, that is, 1-ethoxy-3-methyl-1-oxobut-3-en-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate, SYP-300, that is, 1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidine-4,5-dione, 2,3,6-TBA, TCA (trichloroacetic acid), sodium TCA, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazine, terbutryn, tetflupyrolimet, tenilchlor, thiazopyr, thienecarbazone, thienecarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, thiafenox, toprylate, topramezone, traloxydim, triafamone, triallate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, sodium trifloxysulfuron, trifludimoxazin, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, benolate, ZJ-0862, that is, 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline, methyl (2R, * ,4R * )-4-[[(5S)-3-(3,5-difluorophenyl)-5-vinyl-4H-isoxazole-5-carbonyl]amino]tetrahydrofuran-2-carboxylate.

[0089] At least one active ingredient (a) is preferably selected from the group consisting of fungicides selected from the group consisting of inhibitors of the respiratory chain in the class (1) complex (especially azole-based) described above, (2) inhibitors of the respiratory chain in complex I or II, (3) inhibitors of the respiratory chain in the complex, (4) inhibitors of mitosis and cell division, (6) compounds capable of inducing host defense, (10) inhibitors of lipid and membrane synthesis, and (15).

[0090] More preferably, at least one active ingredient (a) as a fungicide is selected from the group consisting of trifloxystrobin, bixafen, prothioconazole, ipfencarbazone, isoflucypram, and fluoxapiprolin.

[0091] At least one type of insecticide is preferably selected from the group of insecticides including the class (2) GABA-regulated chloride channel antagonists, (3) sodium channel modulators / voltage-dependent sodium channel blockers, (4) nicotinic acetylcholine receptor (nAChR) competitive activators, (23) inhibitors of acetyl-CoA carboxylase, (28) ryanodine receptor modulators, (30) other active ingredients described above.

[0092] Furthermore, more preferably, at least one active ingredient (a) as an insecticide is selected from the group including spirotetramat, deltamethrin and ethiprole.

[0093] Finally, more preferably, at least one active ingredient (a) as a herbicide is selected from the group including triafamone, tembotrione and ethofumesate, preferably in combination with a phytotoxicity reducing agent.

[0094] Even more preferably, at least one active ingredient is selected from the group including trifloxystrobin, bixafen, prothioconazole, imidacloprid, isoflurprim, fluoxapiprolin, spirotetramat, ethiprole, deltamethrin, triafamone, tembotrione and ethofumesate.

[0095] All of the active ingredients described above can exist in the form of the free compound and / or, if possible by their functional groups, in the form of their agrochemically active salts.

[0096] Furthermore, mesomeric forms and stereoisomers or enantiomers should also be included where appropriate, since these variations are as well known to the person skilled in the art as polymorphism.

[0097] Unless otherwise indicated, in the present invention, the solid agrochemical active compound (a) should be understood to mean all substances customary for the treatment of plants having a melting point above 20 °C.

[0098] Polymeric drift-reducing additive (b) Suitable drift-reducing polymers are poly(ethylene oxide), where the polymer preferably has an average molecular weight of 0.5 to 14 million g / mol, more preferably 0.75 to 10 million g / mol, and most preferably 1 to 8 million g / mol, and hydroxypropyl guar (HP guar).

[0099] In one embodiment, the polymeric drift-reducing additive is poly(ethylene oxide) (PEO), where more preferably the formulation shows a polymer concentration factor (PCF) value of 0.5 to 12, more preferably 1 to 10, and even more preferably 2 to 9 with PEO.

[0100] The polymer concentration factor (PCF) for the PEO polymer content in the formulation is defined as follows, where C is the concentration (g / L) of the drift-reducing polymer (b) in the formulation, M is the molar mass (g / mol / 1×10 6 ) of the drift-reducing polymer (b), a is a value of 1.4, and D is the dosage (L / ha) of the formulation per hectare. The PCF value is calculated from the following formula:

Equation

[0101] Oil-based drift-reducing additive (c) Suitable drift-reducing oils are vegetable oils and vegetable oil esters and diesters (including esters with glycerin and propylene glycol).

[0102] Particularly preferred are methyl ester, ethyl ester, isopropyl ester, isobutyl ester, butyl ester, hexyl ester and ethylhexyl ester.

[0103] More preferably, the vegetable oil and ester are selected from the group consisting of methyl oleate, methyl palmitate, rapeseed oil methyl ester, isopropyl myristate, isopropyl palmitate, ethylhexyl palmitate, ethylhexyl oleate, a mixture of ethylhexyl myristate / ethylhexyl laurate, ethylhexyl laurate, a mixture of ethylhexyl caprylate / ethylhexyl capric acid, diisopropyl adipate, coconut oil propylene glycol diester, sunflower oil, rapeseed oil, corn oil, soybean oil, rice bran oil, olive oil, peanut oil, mixed caprylic acid and capric acid triglyceride, and a mixture of mixed decanoyl and octanoyl glyceride.

[0104] Particularly preferred are rapeseed oil, rapeseed oil methyl ester, corn oil, ethylhexyl palmitate, isopropyl palmitate or sunflower oil.

[0105] Furthermore, mineral oil is also suitable as a drift reducer.

[0106] Spreader and uptake-promoting additive (d): Some compounds suitable as spreading agents act as uptake-promoting additives or vice versa due to their chemical properties. Therefore, those compounds are summarized under compound (d).

[0107] A spreading agent is a compound that promotes the spreading of a tank mix additive or a pesticide formulation containing a tank mix additive onto plant parts (particularly leaves).

[0108] Suitable spreading agents are selected from the group comprising the following: Monoesters and diesters of metal sulfosuccinates with branched or straight-chain alcohols containing 1 to 10 carbon atoms, in particular alkali metal salts, more particularly sodium salts, most particularly sodium dioctyl sulfosuccinate; And organosilicone alkoxylates, for example organically modified polysiloxane / trisiloxane alkoxylates, preferably polyalkylene oxide-modified heptamethyltrisiloxane, where the alkylene oxide is preferably selected from ethylene oxide (EO) or propylene oxide (PO), in particular the following: CAS No. 27306-78-1 (Poly(oxy-1,2-ethanediyl),.alpha.-methyl-.omega.-[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propoxy]), CAS No. 67674-67-3 (Poly(oxy-1,2-ethanediyl),.alpha.-[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propyl]-.omega.-hydroxy), CAS No. 134180-76-0 (Oxirane, methyl-, oxirane-containing polymer, mono 3-1,3,3,3-tetramethyl-1-(trimethylsilyl)oxydisiloxanylpropyl ether), for example, Silwet® L77, Silwet® 408, Silwet® 806, BreakThru® S240, BreakThru® S278.

[0109] Another suitable spreading agent is the following: Ethoxylated diacetylene-diols having 1 to 6 ethylene oxide (EO) units, for example, Surfynol® 420 and 440; And an alcohol alkoxylate selected from the group consisting of alcohol alkoxylates, preferably ethoxylated alcohols or propoxy-ethoxylated alcohols, more preferably those containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units, in particular Genapol® EP0244, Genapol® EP2584, or Synergen® W06, or 1-hexanol, 3,5,5-trimethyl-, ethoxylated, propoxylated (CAS-No 204336-40-3), for example, Break-Thru® Vibrant; And further alkyl polysaccharides, for example, Agnique® PG8107, PG8105 manufactured by BASF; Atplus® 438, AL-2559, AL-2575 manufactured by Croda.

[0110] The term "alcohol" in this context refers to a branched or straight-chain saturated or unsaturated alcohol having 6 to 22 carbon atoms, which may optionally have additional substituents such as an OH group.

[0111] Preferably, the spreading agent is Selected from the group consisting of metal sulfosuccinates and mono- and diesters of branched or straight-chain alcohols containing 1 to 10 carbon atoms, organically modified polysiloxane / trisiloxane alkoxylates, ethoxylated diacetylenediols having 1 to 6 ethylene oxide (EO) units, alcohol alkoxylates containing 6 to 22 carbon atoms, or alkyl polysaccharides; More preferably, it is selected from sodium dioctyl sulfosuccinate, polyalkylene oxide-modified heptamethyltrisiloxane, ethoxylated diacetylenediols having 1 to 6 EO units, or ethoxylated alcohols or propoxy-ethoxylated alcohols having 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) units and / or propylene oxide (PO) units; and, in particular, selected from the group consisting of sodium dioctyl sulfosuccinate, polyalkylene oxide-modified heptamethyltrisiloxane, and ethoxylated diacetylenediol having 1 to 6 ethylene oxide units.

[0112] In a further preferred embodiment of the present invention, the spreading agent (c) is selected from the group consisting of polyalkylene oxide-modified heptamethyltrisiloxane, dioctyl sulfosuccinate, alcohol ethoxylate, and ethoxylated diacetylenediol having 1 to 6 EO, and more preferably, selected from the group consisting of polyalkylene oxide-modified heptamethyltrisiloxane, dioctyl sulfosuccinate, and ethoxylated diacetylenediol having 1 to 6 EO.

[0113] The uptake-promoting additive is a compound that promotes the uptake of a tank mix additive or a pesticide formulation containing a tank mix additive into a plant or a part of a plant (particularly, a leaf).

[0114] Suitable uptake-promoting additives are alcohol alkoxylates, preferably alcohol alkoxylates selected from the group consisting of: Ethoxylated alcohol or propoxy-ethoxylated alcohol, more preferably, those containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units; Ethoxylated carboxylic acid or propoxyl-ethoxylated carboxylic acid, preferably, those containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units; Or, an ethoxylated mono-, di-, or triester of glycerin containing a fatty acid having 8 to 18 carbon atoms and an average of 5 to 60 (preferably, 5 to 40) EO units.

[0115] The ethoxylated or propoxy-ethoxylated alcohol or carboxylic acid may optionally be further modified by adding methyl radicals to the remaining alcohol functionality (cf. "Me end cap").

[0116] Further suitable uptake promoting additives are selected from the following: fatty acids having 8 to 18 carbon atoms and alkoxylated sorbitan fatty acid esters containing on average 10 to 50 ethylene oxide and propylene oxide units; or, ethoxylated coconut alcohol containing 2 to 20 EO units; or, castor oil ethoxylate containing on average 5 to 40 EO units.

[0117] The term "alcohol" in this context refers to a branched or straight-chain saturated or unsaturated alcohol having 6 to 22 carbon atoms, which may optionally have additional substituents such as an OH group. The term "carboxylic acid" in this context refers to a branched or straight-chain saturated or unsaturated carboxylic acid having 6 to 22 carbon atoms, which may optionally have additional substituents such as an OH group.

[0118] Preferably, the uptake promoting additive according to (d) is selected from the group consisting of alcohol alkoxylates containing 6 to 22 carbon atoms, ethoxylated carboxylic acids or propoxy-ethoxylated carboxylic acids containing 6 to 22 carbon atoms, fatty acids having 8 to 18 carbon atoms and ethoxylated mono-, di- or triesters of glycerin containing on average 5 to 60 EO units, alkoxylated sorbitan fatty acid esters containing 8 to 18 carbon atoms and on average 10 to 50 ethylene oxide and propylene oxide units, ethoxylated coconut alcohol containing 2 to 20 EO units, or castor oil ethoxylate containing on average 5 to 40 EO units; More preferably, it is selected from ethoxylated alcohols or propoxy-ethoxylated alcohols containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units, ethoxylated carboxylic acids or propoxy-ethoxylated carboxylic acids containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units, ethoxylated mono-, di- or triesters of glycerin containing fatty acids having 8 to 18 carbon atoms and an average of 5 to 60 EO units, or alkoxylated sorbitan fatty acid esters containing fatty acids having 8 to 18 carbon atoms and an average of 10 to 50 ethylene oxide and propylene oxide units, ethoxylated coconut alcohol containing 2 to 20 EO units, or castor oil ethoxylate containing an average of 5 to 40 EO units; And, in particular, it is selected from the group consisting of ethoxylated alcohols or propoxy-ethoxylated alcohols containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units, ethoxylated carboxylic acids or propoxy-ethoxylated carboxylic acids containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide (EO) and / or propylene oxide (PO) units, ethoxylated mono-, di- or triesters of glycerin containing fatty acids having 8 to 18 carbon atoms and an average of 5 to 60 EO units, and alkoxylated sorbitan fatty acid esters containing fatty acids having 8 to 18 carbon atoms and an average of 10 to 50 ethylene oxide and propylene oxide units.

[0119] In a more preferred embodiment of the present invention, the uptake promoter (c) is selected from the group consisting of ethoxylated alcohols, propoxylated ethoxylated alcohols, ethoxylated carboxylic acids, propoxy-ethoxylated carboxylic acids, or ethoxylated mono-, di- or triesters of glycerin containing fatty acids having 8 to 18 carbon atoms and an average of 5 to 40 EO units, and alkoxylated sorbitan fatty acid esters containing fatty acids having 8 to 18 carbon atoms and an average of 10 to 50 EO and PO units.

[0120] Suitable component (d) is, by way of example, the following: * Ethoxylated linear and / or branched fatty alcohols containing 2 to 20 EO units (e.g., Genapol® X types from Clariant); * Methyl-terminated capped ethoxylated linear and / or branched fatty alcohols containing 2 to 20 EO units (e.g., Genapol® XM types from Clariant); * Ethoxylated coconut alcohols containing 2 to 20 EO units (e.g., Genapol® C types from Clariant); * Ethoxylated C12 / 15 alcohols containing 2 to 20 EO units (e.g., Synperonic® A types from Croda); * Propoxy-ethoxylated alcohols, branched or linear, e.g., Antarox® B / 848 from Solvay, Atlas® G5000 from Croda, Lucramul® HOT5902 from Levaco; * Propoxy-ethoxylated fatty acids, Me-terminated cap, e.g., Leofat® OC0503M from Lion; * Alkyl ether citrate surfactants (e.g., Adsee CE range, Akzo Nobel); * Alkyl polysaccharides (e.g., Agnique® PG8107, PG8105 from BASF; Atplus® 438, AL-2559, AL-2575 from Croda); * Ethoxylated mono-esters or di-esters of glycerin containing fatty acids having 8 to 18 carbon atoms and an average of 10 to 60 (preferably 10 to 40) EO units (e.g., Crovol® product range from Croda); * Castor oil ethoxylates containing an average of 5 to 40 EO units (e.g., Berol® range from Nouryon, Emulsogen® EL range from Clariant); * Ethoxylated oleic acid containing 2 to 20 EO units (e.g., Alkamuls® A and AP); * Fatty acids having 8 to 18 carbon atoms and alkoxylated sorbitan fatty acid esters containing an average of 10 to 50 EO and / or PO units (e.g., Arlatone® T, Tween range).

[0121] Other formulation aids (e): In connection with the present invention, the other formulation aids (e) are further additives commonly used in pesticide formulations and are not included in components (a) to (d).

[0122] Preferably, the other formulation aids are one or more substances selected from rainfastness additives, surfactants, rheology modifiers, defoaming substances, antifreezing agents, preservatives, biocides, colorants, pH adjusters, buffers, stabilizers, antioxidants, inert fillers, wetting agents, crystal growth inhibitors or micronutrients.

[0123] More preferably, the other formulation aids (e) contain at least one nonionic surfactant and / or ionic surfactant, one rheology modifier, one defoaming substance and at least one antifreezing agent.

[0124] (e1) Rainfastness additive: Suitable weather resistance additives are acrylic emulsion polymers or polymer dispersions, and styrene emulsion polymers or polymer dispersions (d), which are aqueous polymer dispersions having a Tg in the range of -100°C to 30°C, preferably -60°C to 20°C, more preferably -50°C to 10°C, and most preferably -45°C to 5°C, such as Acronal V215, Acronal 3612, Licomer ADH205 and Atplus FA. Particularly preferred are Licomer ADH205 and Atplus FA.

[0125] Preferably, the polymer is selected from the group consisting of acrylic polymers, styrene polymers, vinyl polymers and their derivatives, polyolefins, polyurethanes, and natural polymers and their derivatives.

[0126] More preferably, the polymer is selected from the group consisting of acrylic polymers, styrene-butadiene copolymers, styrene-maleic anhydride copolymers, polyvinyl alcohol, polyvinyl acetate, partially hydrolyzed polyvinyl acetate, methyl vinyl ether-maleic anhydride copolymers, carboxy-modified polyvinyl alcohol, acetoacetyl-modified polyvinyl alcohol, diacetone-modified polyvinyl alcohol, and silicon-modified polyvinyl alcohol, isopropylene-maleic anhydride copolymers, polyurethanes, cellulose, gelatin, casein, oxidized starch, starch-vinyl acetate graft copolymer, hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, carboxymethyl cellulose and acetyl cellulose.

[0127] Most preferably, the polymer is selected from copolymers of acrylate and styrene. The acrylate is selected from the list including 2-ethyl-hexyl acrylate, butyl acrylate, sec-butyl acrylate, ethyl acrylate, methyl acrylate, acrylic acid, acrylamide, iso-butyl acrylate, methyl methacrylate or combinations thereof. The styrene is selected from the list including styrene, tert-butyl styrene, para-methyl styrene or combinations thereof.

[0128] In a preferred embodiment, the polymer described above has a molecular weight of 40,000 g / mol or less, preferably 10,000 g / mol or less.

[0129] In a preferred embodiment, Polymer D is an emulsion polymer described in WO2017 / 202684.

[0130] The glass transition temperature (Tg) is known for many polymers. In the present invention, when not otherwise defined, it is measured according to ASTM E1356-08(2014) "Standard Test Method for Assignment of the Glass Transition Temperatures by Differential Scanning Calorimetry". At that time, the sample is dried at 110 °C for 1 hour before DSC to remove the influence of water and / or solvent. The DSC sample size is 10 - 15 mg, and N 2 Under a nitrogen atmosphere, it is measured at 20 °C / min from -100 °C to 100 °C. Tg is defined as the midpoint of the transition region.

[0131] (e2) Surfactant: Suitable non-ionic surfactants or dispersants (e1) are all substances of this type customarily used in pesticides. Preferably, polyethylene oxide-polypropylene oxide block copolymers (preferably having a molecular weight exceeding 5000 g / mol or a polyethylene oxide content exceeding 35%, more preferably having a molecular weight exceeding 6000 g / mol and a polyethylene oxide content exceeding 45%), polyoxyalkylene amine derivatives, polyvinylpyrrolidone, copolymers of polyvinyl alcohol and polyvinylpyrrolidone, and copolymers of (meth)acrylic acid and (meth)acrylic acid esters. Among the above examples, the selected classes may optionally be phosphorylated, sulfonated or sulfated and may also be neutralized with a base.

[0132] Possible anionic surfactants are all substances of this type customarily used in pesticides. Alkali metal salts, alkaline earth metal salts and ammonium salts of alkylsulfonic acids or alkylphosphoric acids are preferred, as are alkylarylsulfonic acids or alkylarylphosphoric acids. A further preferred group of anionic surfactants or dispersants are the alkali metal salts, alkaline earth metal salts and ammonium salts of polystyrenesulfonic acid, salts of polyvinylsulfonic acid, salts of alkylnaphthalenesulfonic acid, salts of naphthalene-sulfonic acid-formaldehyde condensation products, salts of condensation products of naphthalenesulfonic acid, phenolsulfonic acid and formaldehyde, and salts of lignosulfonic acid.

[0133] (e3) Rheology modifier: A rheology modifier is an additive that, when added to a formulation at a concentration that reduces the gravitational separation of the dispersed active ingredient during storage, results in a substantial increase in viscosity at low shear rates. For the purposes of the present invention, low shear rates are defined as 0.1 s -1 as defined below and substantial increase is defined as exceeding twofold. The viscosity can be measured with a rotational shear rheometer.

[0134] Suitable rheology modifiers (e3) are, for example, as follows: * Polysaccharides including xanthan gum and hydroxyethyl cellulose. Examples thereof are Kelzan®, Rhodopol® G and 23, Satiaxane® CX911, and Natrosol® 250 range; * Clays including montmorillonite, bentonite, sepiolite, attapulgite, laponite, hectorite. Examples thereof are Veegum® R, VanGel® B, Bentone® 34, 38, CT, HC, EW, Pangel® M100, M200, M300, S, M, W, Attagel® 50, Laponite® RD; * Fumed silica and precipitated silica, examples of which are Aerosil® 200, Sipernat® 22; * Microcrystalline cellulose.

[0135] Preferred are xanthan gum, montmorillonite clay, bentonite clay and fumed silica.

[0136] (e4) Defoaming substance: Suitable defoaming substances (e4) are all substances customarily usable in pesticides for this purpose. Silicone oils and silicone oil preparations are preferred. Examples thereof are Silcolapse® 426 and 432 manufactured by Bluestar Silicones, Silfoam® SRE and SC132 manufactured by Wacker, SAF-184® manufactured by Silchem, Foam-Clear ArraPro-S® manufactured by Basildon Chemical Company Ltd, SAG® 1572 and SAG® 30 manufactured by Momentive [dimethyl siloxanes and silicones, CAS No. 63148-62-9]. Preferred is SAG® 1572.

[0137] (e5) Antifreeze: Suitable antifreezes are all substances customarily usable in pesticides for this purpose. Suitable examples are propylene glycol, ethylene glycol, urea and glycerin.

[0138] (e6) Further formulation aids: Suitable further formulation auxiliaries (e6) are selected from preservatives, biocides, colorants, pH regulators, buffers, stabilizers, antioxidants, inert filling substances, humectants, crystal growth inhibitors, micronutrients.

[0139] These examples are as follows.

[0140] Possible preservatives are all substances customarily usable in pesticides for this purpose. Suitable examples of preservatives are preparations containing 5-chloro-2-methyl-4-isothiazolin-3-one [CAS-No. 26172-55-4], 2-methyl-4-isothiazolin-3-one [CAS-No. 2682-20-4] or 1,2-benzisothiazol-3(2H)-one [CAS-No. 2634-33-5]. Examples that can be mentioned are Preventol® D7 (Lanxess), Kathon® CG / ICP (Dow), Acticide® SPX (Thor GmbH) and Proxel® GXL (Arch Chemicals).

[0141] Possible colorants are all substances customarily usable in pesticides for this purpose. Examples that can be cited are titanium dioxide, carbon black, zinc oxide, blue pigments, Brilliant Blue FCF, red pigments and Permanent Red FGR.

[0142] Possible pH regulators and buffers are all substances customarily usable in pesticides for this purpose. Citric acid, sulfuric acid, hydrochloric acid, sodium hydroxide, sodium hydrogen phosphate (Na 2 HPO 4 ) and sodium dihydrogen phosphate (NaH 2 PO4 ) Potassium dihydrogen phosphate (KH 2 PO 4 ), potassium hydrogen phosphate (K 2 HPO 4 ) can be cited as an example.

[0143] Suitable stabilizers and antioxidants are all substances customarily used in pesticides for this purpose. Butylated hydroxytoluene [3,5-di-tert-butyl-4-hydroxytoluene, CAS-No. 128-37-0] is preferred.

[0144] Carrier (f) is a carrier customarily used in pesticide formulations for this purpose.

[0145] Carrier is generally an inert solid or liquid natural or synthetic organic or inorganic substance that can be used as a solvent. The carrier generally improves the application of the compound, for example, to plants, plant parts or seeds. Examples of suitable solid carriers include, but are not limited to, ammonium salts, especially ammonium sulfate, ammonium phosphate and ammonium nitrate, natural rock powders such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, silica gel, and synthetic rock powders such as micronized silica, alumina and silicates. Examples of typically useful solid carriers for preparing granules include, but are not limited to, crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, synthetic granules composed of inorganic and organic powders, and granules composed of organic materials such as paper, sawdust, coconut shells, corn cobs and tobacco stalks.

[0146] Preferred solid carriers are selected from clay, talc and silica.

[0147] Examples of suitable liquid carriers include, but are not limited to, water, organic solvents, and combinations thereof. Examples of suitable solvents include polar and nonpolar organic chemical liquids such as those selected from the following classes: * Alcohols and polyols (which may optionally be substituted, etherified, and / or esterified; for example, ethanol, propanol, butanol, benzyl alcohol, cyclohexanol, or glycol, 2-ethylhexanol); * Ethers, such as dioctyl ether, tetrahydrofuran, dimethyl isosorbide, solketal, cyclopentyl methyl ether, solvents provided by Dow under the "Dowanol Product Range", such as Dowanol DPM, anisole, phenetole, dimethyl polyethylene glycols of various molecular weight grades (less than 1000 g / mol), dimethyl polypropylene glycols of various molecular weight grades (less than 1000 g / mol), dibenzyl ether; * Ketones (e.g., acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclopentanone, cyclohexanone, cycloheptanone, acetophenone, propiophenone); * Lactate esters, such as methyl lactate, ethyl lactate, propyl lactate, butyl lactate, 2-ethylhexyl lactate; * Unsubstituted and substituted amines; * Amides (e.g., dimethylformamide, or N,N-dimethyl lactamide, or N-formylmorpholine, or fatty acid amides, such as N,N-dimethyldecanamide or N,N-dimethyldec-9-enamide) and their esters; * Lactams (e.g., 2-pyrrolidone, or N-alkylpyrrolidones, such as N-methylpyrrolidone, or N-butylpyrrolidone, or N-octylpyrrolidone, or N-dodecylpyrrolidone, or N-methylcaprolactam, N-alkylcaprolactam); * Lactones (e.g., gamma-butyrolactone, gamma-valerolactone, delta-valerolactone, or alpha-methyl-gamma-butyrolactone); * Sulfones and sulfoxides (e.g., dimethyl sulfoxide); * Nitriles (e.g., linear alkyl nitriles or cyclic alkyl nitriles, especially acetonitrile, cyclohexanecarbonitrile, octanonitrile, dodecanonitrile); * Linear and cyclic carbonates, such as diethyl carbonate, dipropyl carbonate, dibutyl carbonate, dioctyl carbonate, or ethylene carbonate, propylene carbonate, butylene carbonate, carbonate.

[0148] The most preferred carrier is water.

[0149] Using the formulations according to the invention, it is possible to deliver the pesticidal active substance to plants and / or their habitat in a particularly advantageous way.

[0150] The invention further relates to the use of the pesticidal formulations according to the invention for applying the pesticidal active compounds contained therein to plants and / or their habitat.

[0151] Using the formulations of the present invention, all plants and parts of plants can be treated. Here, the term "plant" means all plants and plant populations such as desirable and undesirable wild plants or crop plants (including naturally occurring crop plants). Crop plants can be obtained by conventional breeding and optimization methods, or by biotechnological and genetic engineering methods, or by a combination of these methods. Such crop plants include transgenic plants and also include plant varieties that can be protected by variety rights and plant varieties that cannot be protected. Parts of plants mean all above-ground and underground parts and all organs of plants such as shoots, leaves, flowers and roots, and an exemplary list includes leaves, needles, stems, trunks, flowers, fruiting bodies, fruits and seeds, and further includes roots, tubers and rhizomes. Parts of plants further include harvests and also include vegetative and generative propagation material.

[0152] The application rate of the formulation according to the present invention or the spraying liquid containing the formulation can be varied within a relatively wide range. It is guided by the specific active pesticide and by their amounts in the formulation or spraying liquid.

[0153] The formulation according to the present invention or the spraying liquid containing the formulation is applied by conventional methods, i.e., for example, by spraying, pouring or injection, in particular by spraying, most specifically by spraying with an unmanned aerial vehicle UAV or an unmanned guided vehicle UGV, or by a spraying nozzle device using pulse width modulation PWM.

[0154] A further aspect of the present invention is the use of the formulation according to the present invention in the application of pesticidal compounds for controlling pests, where the formulation or the spraying liquid containing the formulation is applied by an unmanned aerial vehicle UAV or an unmanned guided vehicle UGV, or by a spraying nozzle device using pulse width modulation PWM.

[0155] Drawings Figure 1 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example FN1.

[0156] Figure 2 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example FN2.

[0157] Figure 3 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example FN3.

[0158] Figure 4 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example FN4.

[0159] Figure 5 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example FN5.

[0160] Figure 6 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example FN6.

[0161] Figure 7 shows the spray droplet size % <100 microns for different PEO polymer molar masses and concentrations for Example Polymer 1.

[0162] Figure 8 shows the spray droplet size % <100 microns for different PEO polymer molar masses and PCF values for Example Polymer 2.

[0163] Figure 9 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example IN1.

[0164] Figure 10 shows the spray droplet size % <100 microns for different spray liquid amounts for the formulation in Example HB1.

[0165] Figure 11 shows the percentage of spray droplet size <100 microns for different spray liquid amounts for the formulation in Example HB2.

[0166] Figure 12 shows the percentage of spray droplet size <100 microns for different spray liquid amounts for the formulation in Example HB3.

[0167] Figure 13 shows the percentage of spray droplet size <100 microns for different spray liquid amounts for the formulation in Example HB4.

[0168] Figure 14 shows the percentage of spray droplet size <100 microns for different spray liquid amounts for the formulation in Example HB5.

[0169] Table of materials Materials [Table 1] [Table 2] TIFF2025516343000004.tif33160 [Table 3] TIFF2025516343000006.tif77163 [Table 4] [Table 5] [Table 6] TIFF2025516343000010.tif206168 Experimental method Method 1: Preparation of flowable SC Methods for preparing flowable suspension formulations are known in the art and can be manufactured by well-known methods to those skilled in the art. The 5% gel of Van Gel B(e) was prepared by mixing a 5% dispersion in water under high shear. The 2% gel in water of Rhodopol 23 (xanthan)(e) and the biocide(e) were prepared by low shear stirring. The 1-4% solution of the drift-reducing polymer(b) was prepared by mixing the polymer in glycerin(25%) and pouring the mixture into water(up to 100%) while stirring until homogeneous. The 50% oil-in-water emulsion of the drift-reducing oil(c) was prepared by adding the oil(50%) to a solution of water(49%) and Synperonic PE / F127(1%) under high shear mixing(Ultra-Turrax®) to achieve a droplet size(Dv50) of 1-4 microns. The active ingredient(a), nonionic dispersant(e), anionic dispersant(e), antifoaming agent(e) and other formulation aids(e) were mixed with water to form a slurry, first mixed with a high shear rotor-stator mixer(Ultra-Turrax®) to reduce the particle size D(v,0.9) to about 50 microns, and then passed through one or more bead mills(Eiger® 250 Mini Motormill) to typically achieve a particle size D(v,0.9) of 1-15 microns. Then, if present in the formulation, the spreading agent and / or uptake promoting additive(d) was added and mixed with stirring, followed by adding the polymer(b) solution prepared above, the 50% oil(c) emulsion prepared above, the 5% Van Gel B gel prepared above and the 2% Rhodopol 23 (xanthan) gel, and mixing with low shear stirring until homogeneous. Water was added further if necessary to the final amount. Finally, the pH was adjusted to pH 6.5 - pH 7.5 using an acid or base(e) if necessary.

[0170] The polymer (b) solution is prepared according to the viscosity-concentration limit and content required in the formulation. Examples of typical values are as follows: Polyox WSR301 (1-2%), Polyox WSR N60K (1-3%), Polyox WSR N12K (2-4%), AgRho DR2000 (1-2%).

[0171] A flowable formulation containing a small amount of emulsified oil can be described as both a suspension formulation and a suspoemulsion formulation ( www.croplife.org , Technical Monograph No:2, Catalogue of pesticide formulation types and international coding system, Edition: March 2017).

[0172] Method 2: Measurement of spray droplet size P15 The formulation was diluted with water (deionized water) to the required concentration, sprayed at a pressure of 3 bar through a TeeJet® TP8002EVS nozzle, and the spectrum of droplet sizes was measured using an Oxford Lasers VisiSize P15 which acquired images of the sprayed droplets and measured their sizes. The spray nozzle was positioned 20 cm above the image acquisition point and slowly moved with an electric slider across the image acquisition window of the VisiSize P15, thereby ensuring that the full width of the spray fan was measured. At least 5000 - 10000 droplet images were acquired. The spectrum of droplet sizes was calculated by the instrument software as the volume % less than 100 microns and the volume % less than 150 microns, which are generally regarded as the parts of the sprayed droplets that are prone to drift.

[0173] Method 3: Viscosity measurement Viscosity was measured at 22 °C using a rotational shear rheometer while increasing the shear rate range from 0.2 to 1000 s -1 up to. The measurements were taken at 1 s -1 , 20 s -1 and 100 s -1Performed at a logarithmically spaced series of shear rates including it, and recorded its viscosity. The sample was not subjected to pre-shear prior to measurement.

[0174] Method 4: Preparation method of SL Methods for preparing soluble formulations are known in the art and can be produced by known methods well known to those skilled in the art. A 1-4% solution of the drift-reducing polymer (b) was prepared by mixing the polymer in glycerin (25%) and pouring the mixture into water (up to 100%) while stirring until homogeneous. A 50% oil-in-water emulsion of the drift-reducing oil (c) was prepared by adding the oil (50%) to a solution of water (49%) and Synperonic PE / F127 (1%) under high shear mixing (Ultra-Turrax®) to achieve a droplet size (Dv50) of 1-4 microns. The active ingredient (a) was pre-neutralized with a base (e.g., diglycolamine) and added as a 55% aqueous solution to the other surfactants while stirring. Further water was added to make up the total volume. The active ingredient (a), other formulation adjuvants (e), spreading additives and / or uptake-promoting additives (d) were mixed with water while stirring, and then the polymer (b) solution prepared above and the 50% oil (c) emulsion prepared above were mixed with low shear until homogeneous. Finally, the pH was adjusted with an acid or base (e) if necessary.

[0175] --------------------------------------

Example

[0176] Examples Fungicide Example FN1: Trifloxystrobin 80SC

Table 7

Table 8

[0177] Spray droplet size The spray droplet size was measured according to Method 2. [Table 9] The above results indicate that by adding rapeseed oil, it is possible to reduce the fractions of spray droplets that can drift below 100 microns and 150 microns at high spray liquid volumes, and by adding the polymer AgRho® DR2000, it is possible to reduce the fraction of spray droplets that can drift at low spray liquid volumes. However, it was found that only the combination of rapeseed oil and the AgRho® DR2000 polymer can reduce the fraction of spray droplets that can drift at both high and low spray liquid volumes. Furthermore, the amount of the AgRho® DR2000 polymer is important. To reduce it at low spray liquid volumes, 2 g / L is insufficient, while 6 g / L and 10 g / L are sufficient (see Figure 1). This corresponds to only 6 - 10 g of polymer / ha, which is surprisingly little to reduce the fraction of spray droplets that can drift. Additionally, the amount of rapeseed oil required to reduce the fraction of spray droplets that can drift is far below the typical usage amounts of these materials, which is also surprisingly small. The corresponding concentrations in the spray liquid are shown in Table FN1.4, and the combination of 0.06 - 2.4 g / L of rapeseed oil and 0.03 - 2.0 g / L of the AgRho® DR2000 polymer in the spray liquid (FN1.3 and FN1.5) shows that the observed reduction in the fraction of spray droplets that can drift in Table FN1.3 is achieved.

Table 10

Table 11

Table 12

[0178] Spray droplet size The spray droplet size was measured according to Method 2. [Table 13] The above results indicate that by combining the polymer Polyox® WSR301 (PEO 4 million) and the oil Crodamol® OP, it is possible to reduce the driftable fraction of spray droplets less than 100 microns and less than 150 microns in the range of spray liquid amounts of 5 - 200 L / ha (see Figure 2). The amounts of the polymer Polyox® WSR301 and the oil applied per hectare are 1 g / ha and 5 g / ha, respectively, and these amounts are extremely small and are significantly lower than the general usage amounts for these materials. The corresponding concentrations in the spray liquid are shown in Table FN2.4. [Table 14] Example FN3: Isoflucypram SC [Table 15] Physical aspects The physical aspects regarding viscosity were visually evaluated. [Table 16] The above results indicate that the polymer Polyox® WSR N12K can be incorporated into the SC formulation at a concentration of 2.0 g / L.

[0179] Spray droplet size The spray droplet size was measured according to Method 2. [Table 17] The above results indicate that by combining the polymer Polyox® WSR N12K (PEO 1 million) and methylated rapeseed oil, it is possible to reduce the driftable fractions of spray droplets less than 100 microns and less than 150 microns in the range of spray liquid amounts from 5 to 200 L / ha (see Figure 3). The amounts of the polymer Polyox® WSR N12K and oil applied per hectare are 1 g / ha and 5 g / ha, respectively, and these amounts are extremely small and far below the typical usage amounts for these materials. The corresponding concentrations in the spray liquid are shown in Table FN3.4. Here, the effects at low spray liquid amounts (5 and 10 L / ha) are limited, which means that 2 g / L of Polyox® WSR N12K in the formulation applied at 0.5 L / ha corresponding to a dosage of 1 g / ha is the lower limit, and below this, the polymer concentration is too low to affect the spray droplet size.

Table 18

Table 19

Table 20

[0180] Spray droplet size The spray droplet size was measured according to Method 2.

Table 21

[0181] Spray droplet size The spray droplet size was measured according to Method 2. [Table 25] The above results indicate that by combining the polymer Polyox® WSR301 with corn oil, it is possible to reduce the driftable fraction of spray droplets less than 100 microns and less than 150 microns in the range of spray liquid amounts from 5 to 200 L / ha (see Figure 5). The amounts of Polyox® WSR301 and oil applied per hectare are 1 g / ha and 5 g / ha, respectively, and these amounts are extremely small and far below the general usage amounts for these materials. Furthermore, it can be seen that Polyox® WSR301 shows a stronger effect than Polyox® WSR N12K (Examples FN2 and FN3), indicating that higher molecular weight (molar mass) grades of PEO are more effective at the same usage amount and can reduce the usage amount in the formulation.

Table 26

Table 27

Table 28

[0182] Spray droplet size The spray droplet size was measured according to Method 2.

Table 29

Table 30

Table 31

[0183] For k-carrageenan and xanthan polymers, a limited reduction in the driftable fraction of spray droplets is observed. However, the amount of polymer required in the formulation to achieve a significant reduction in the driftable fraction of spray droplets is very large, and as a result, at such amounts, the viscosity of the formulation is too high to be poured from a bottle and dispersed into the spray liquid. Furthermore, xanthan (Rhodopol® 23) is commonly used in SC formulations and its usage amount is usually 2 - 3.5 g / L. Although this concentration is sufficiently low, as shown in Table P1.1, the concentration in the spray liquid is not sufficient to significantly reduce the fraction of driftable droplets.

[0184] Example Polymer 2:

Table 32

[0185] To clarify this effect, the polymer concentration factor (PCF) with respect to the PEO polymer content in the formulation is defined as follows, where C is the concentration (g / L) of the drift-reducing polymer (b) in the formulation, M is the molar mass (g / mol / 1×10 6 ) of the drift-reducing polymer (b), a has a value of 1.4, and D is the dose (L / ha) of the SC (or formulation) per hectare. The PCF value is calculated from the following formula:

Equation

Table 33

Table 34

Table 35

[0186] Spray droplet size The spray droplet size was measured according to Method 2.

Table 36

Table 37

Table 38

Table 39

Table 47

Table 48

Table 49

Table 50

Table 51

Table 52

Table 53

Table 54

Table 55

Table 56

Table 57

Claims

1. It is a pesticide preparation, (a) One or more active ingredients; (b) One or more polymer-based drift-reducing additives selected from the group consisting of poly(ethylene oxide) and hydroxypropylated guar; (c) One or more oil-based drift-reducing additives; (d) One or more spreading agents and / or uptake-promoting additives; (e) Other pharmaceutical adjuvants; (f) one or more carriers up to a predetermined volume, at least one of which is water; Here, (a) is present in concentrations of 10 to 550 g / L; (b) is present in concentrations of 0.2 to 50 g / L; (c) is present in concentrations of 0.5 to 45 g / L; (d) is present in concentrations of 10 to 200 g / L; (e) is present in concentrations of 20–300 g / L; A pesticide formulation characterized by the following features.

2. (a) is present in concentrations of 20 to 200 g / L; (b) is present in concentrations of 1 to 15 g / L; (c) is present in concentrations of 5 to 25 g / L; (d) is present in concentrations of 25–140 g / L; (e) is present in concentrations of 30–135 g / L; (f) A carrier up to a predetermined volume; The pesticide formulation according to claim 1.

3. The agrochemical formulation according to claim 1 or 2, wherein (b) is preferably selected from the group comprising poly(ethylene oxide) having an average molecular weight of 0.5 to 14 million g / mol, more preferably 0.75 to 10 million g / mol, and most preferably 1 to 8 million g / mol.

4. The agricultural chemical formulation according to claim 3, wherein the formulation has 1 to 10 PCFs.

5. The polymer concentration coefficient (PCF) for the PEO polymer content in the aforementioned formulation is given by the following formula: [Math 1] [Calculated from the formula, where C is the concentration (g / L) of the drift-reducing polymer (a) in the formulation, M is the molar mass (g / mol / 1 × 10⁶) of the drift-reducing polymer (a), a is a value of 1.4, and D is the amount of the formulation per 1 ha (L / ha)] The pesticide formulation according to claim 4.

6. (c) is selected from the group comprising vegetable oils and vegetable oil esters and diesters, which include esters of glycerin and propylene glycol, as in the pesticide formulation according to claim 1 or 2.

7. The agrochemical formulation according to claim 1 or 2, wherein the spreading agent (d) is selected from the group comprising sodium dioctyl sulfosuccinate, polyalkylene oxide-modified heptamethyltrisiloxane, ethoxylated diacetylenediol having 1 to 6 ethylene oxide units, or ethoxylated alcohol or propoxy-ethoxylated alcohol having 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide units and / or propylene oxide units, and is preferably selected from sodium dioctyl sulfosuccinate, polyalkylene oxide-modified heptamethyltrisiloxane, and ethoxylated diacetylenediol having 1 to 6 ethylene oxide units.

8. The uptake-promoting additive (d) is selected from the group comprising: alcohol alkoxylates containing 6 to 22 carbon atoms; ethoxylated carboxylic acids or propoxyethoxylated carboxylic acids containing 6 to 22 carbon atoms; ethoxylated mono-, di-, or triesters of glycerin containing 8 to 18 carbon atoms and an average of 5 to 60 ethylene oxide units; alkoxylated sorbitan fatty acid esters containing 8 to 18 carbon atoms and an average of 10 to 50 ethylene oxide and propylene oxide units; ethoxylated coconut alcohol containing 2 to 20 EO units; or castor oil ethoxylates containing an average of 5 to 40 EO units, preferably containing 6 to 22 A pesticide formulation according to claim 1 or 2, selected from an ethoxylated alcohol or propoxyethoxylated alcohol containing 1 carbon atoms and an average of 5 to 40 ethylene oxide and / or propylene oxide units; an ethoxylated carboxylic acid or propoxyethoxylated carboxylic acid containing 6 to 22 carbon atoms and an average of 5 to 40 ethylene oxide and / or propylene oxide units; an ethoxylated mono-, di-, or triester of glycerin containing a fatty acid having 8 to 18 carbon atoms and an average of 5 to 60 ethylene oxide units; or an alkoxylated sorbitan fatty acid ester containing a fatty acid having 8 to 18 carbon atoms and an average of 10 to 50 ethylene oxide and propylene oxide units.

9. The pesticide formulation according to claim 1 or 2, wherein the ratio of (b) to (c) in the formulation is 1:40 to 10:1, more preferably 1:10 to 5:1, and most preferably 1:6 to 2:

1.

10. The pesticide formulation according to claim 1 or 2, wherein the ratio of (b), (c), and (d) in the formulation is 1:40:150 to 10:1:10, more preferably 1:12:120 to 2:1:5, and most preferably 1:8:50 to 1:2:

5.

11. The active ingredients include trifloxystrobin, bixafen, prothioconazole, impulfluxam, isoflucipram, fluoxapiproline, spirotetramat, ethiprole, deltamethrin, triafamone, tenbotrione, etofmesate, and methyl A pesticide formulation according to claim 1 or 2, selected from the group consisting of (2R*,4R*)-4-[[(5S)-3-(3,5-difluorophenyl)-5-vinyl-4H-isoxazole-5-carbonyl]amino]tetrahydrofuran-2-carboxelate.

12. The agricultural chemical formulation according to claim 1 or 2, wherein the other formulation aid (e) is one or more substances selected from rainproofing additives, surfactants, rheology modifiers, defoaming substances, antifreezes, preservatives, biocides, colorants, pH adjusters, buffers, stabilizers, antioxidants, inert fillers, wetting agents, crystal growth inhibitors, or micronutrients.

13. The pesticide formulation according to claim 11, wherein the other formulation aid (e) comprises at least one nonionic surfactant and / or an ionic surfactant, one rheology modifier, one antifoaming substance, and at least one antifreeze.

14. A method for applying the formulation described in claim 1 or 2 to a crop, wherein the formulation is applied in a spray volume of 1 L / ha to 2000 L / ha, preferably 5 L / ha to 1500 L / ha, and more preferably 8 L / ha to 1200 L / ha.

15. A method for applying the pesticide formulation described in claim 1 or 2 to a crop, wherein the formulation is applied in a spray volume of 1 L / ha to 20 L / ha, preferably 2 L / ha to 15 L / ha, and more preferably 5 L / ha to 15 L / ha.

16. In the agricultural area, (b) in an amount of 0.5 to 15 g / ha, more preferably 1 to 12 g / ha, most preferably 1 to 10 g / ha, and (c) in amounts of 0.5 to 40 g / ha, more preferably 1 to 20 g / ha, most preferably 2 to 10 g / ha, and (d) in an amount of 10 to 200 g / ha, more preferably 15 to 160 g / ha, and most preferably 20 to 100 g / ha. Use of the formulation according to claim 1 or 2 for delivering the product.

17. In the use of the pesticide formulation according to claim 1 or 2 for the application of pesticide compounds to control harmful organisms, wherein the formulation or a spray solution containing the formulation is applied by an unmanned aerial vehicle (UAV) or an unmanned guided vehicle (UGV), or by a spray nozzle device using pulse width modulation (PWM).

Images